ENTOD Pharmaceuticals to Contest DCGI Suspension of PresVu Eye Drops Licenses ...Middle East

ENTOD Pharmaceuticals CEO Nikkhil K Masurkar announced that the company will challenge the Drugs Controller General of India's (DCGI) suspension of their manufacturing and marketing licenses for PresVu eye drops. This action follows the company's failure to address DCGI's queries regarding the product, for which no official approval was given.

Hence then, the article about entod pharmaceuticals to contest dcgi suspension of presvu eye drops licenses was published today ( Wednesday 11/09/2024 - 08:57 PM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( ENTOD Pharmaceuticals to Contest DCGI Suspension of PresVu Eye Drops Licenses )

Also on site :

• Pro-Palestinian marches must not promote anti-Jewish violence
• Free speech must apply to everyone at UC —not just the radical left
• Michael Goodwin: The British ambassador was right —the ‘special relationship’ is in tatters